Financial Ratios T. Rowe Price Group, Inc.

Stocks

TROW

US74144T1088

Investment Management & Fund Operators

Real-time Estimate Cboe BZX Other stock markets 21:01:22 16/07/2026 BST			5-day change	1st Jan Change
114.72 ^USD	-3.25%		+1.65%	+16.21%

04:35pm	T. Rowe Price Debuts T. Rowe Price Active Crypto ETF	CI
07-15	AdvanCell Isotopes Pty Ltd. announced that it has received $315 million in funding from a group of investors	CI

400d3eb1366ddd1fb7bf6313592.WhqjAezH6_X7iBWLVyoJk72Ocm-jUm2fw8xEO0S_0sY.H2_CcKK1h7GV6mDYBEVT9Y_iQxuWJzLSi44bcw7vt6cDT_BbtvPam4Pxfg

Published financial data: T. ROWE PRICE GROUP, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	7.67B	6.49B	6.46B	7.09B	7.31B
Total Revenues	7.67B	6.49B	6.46B	7.09B	7.31B
Cost of Goods Sold, Total	2.99B	2.92B	3.25B	3.41B	3.56B
Gross Profit	4.68B	3.57B	3.21B	3.68B	3.75B
Selling General & Admin Expenses, Total	937M	1.07B	1.17B	1.21B	1.27B
Depreciation & Amortization - (IS)	-	-	-	-	-
Amortization of Goodwill and Intangible Assets - (IS)	-	284M	134M	126M	108M
Other Operating Expenses	-	-	-	-	-
Other Operating Expenses, Total	937M	1.35B	1.3B	1.33B	1.38B
Operating Income	3.74B	2.21B	1.9B	2.35B	2.37B
Interest And Investment Income	290M	-	520M	494M	685M
Net Interest Expenses	290M	-	520M	494M	685M
Other Non Operating Income (Expenses)	-5.9M	-17.3M	-15.7M	-7.2M	1.9M
EBT, Excl. Unusual Items	4.03B	2.2B	2.41B	2.84B	3.06B
Restructuring Charges	-	-	-	-	-177M
Merger & Related Restructuring Charges	-31.9M	-900K	-	-	-
Gain (Loss) On Sale Of Investments	-	-408M	-	-	-
Asset Writedown	-	-	-	-31.1M	-3.3M
Insurance Settlements	-	-	-	-	-
Other Unusual Items	-	161M	82.4M	13.4M	-
EBT, Incl. Unusual Items	3.99B	1.95B	2.49B	2.82B	2.88B
Income Tax Expense	896M	499M	655M	684M	667M
Earnings From Continuing Operations	3.1B	1.45B	1.84B	2.14B	2.21B
Net Income to Company	3.1B	1.45B	1.84B	2.14B	2.21B
Minority Interest	-15.6M	108M	-47M	-35.7M	-121M
Net Income - (IS)	3.08B	1.56B	1.79B	2.1B	2.09B
Preferred Dividend and Other Adjustments	80.5M	36.1M	44.4M	55.8M	50.6M
Net Income to Common Incl Extra Items	3B	1.52B	1.74B	2.04B	2.04B
Net Income to Common Excl. Extra Items	3B	1.52B	1.74B	2.04B	2.04B
Per Share Items
Net EPS - Basic	13.25	6.73	7.78	9.18	9.26
Basic EPS - Continuing Operations	13.25	6.73	7.78	9.18	9.26
Basic Weighted Average Shares Outstanding	227M	226M	224M	223M	220M
Net EPS - Diluted	13.12	6.7	7.76	9.15	9.24
Diluted EPS - Continuing Operations	13.12	6.7	7.76	9.15	9.24
Diluted Weighted Average Shares Outstanding	229M	227M	225M	223M	220M
Normalized Basic EPS	11.04	6.55	6.51	7.8	8.13
Normalized Diluted EPS	10.93	6.52	6.49	7.78	8.12
Dividend Per Share	4.32	4.8	4.88	4.96	5.08
Payout Ratio	32.51	71.08	62.71	54.07	54.76
Supplemental Items
EBITDA	3.95B	2.68B	2.39B	2.82B	2.84B
EBITA	3.74B	2.46B	2.13B	2.57B	2.57B
EBIT	3.74B	2.21B	1.9B	2.35B	2.37B
EBITDAR	3.98B	2.73B	2.44B	2.87B	2.9B
Total Revenues (As Reported)	7.67B	6.49B	6.46B	7.09B	7.31B
Effective Tax Rate - (Ratio)	22.43	25.59	26.29	24.25	23.2
Current Domestic Taxes	924M	690M	622M	747M	526M
Current Foreign Taxes	28.1M	15.5M	23.9M	24.7M	44.7M
Total Current Taxes	952M	706M	646M	772M	570M
Total Deferred Taxes	-56.3M	-207M	8.6M	-88M	96.8M
Normalized Net Income	2.5B	1.48B	1.46B	1.74B	1.79B
Supplemental Operating Expense Items
Advertising Expense	100M	97.3M	114M	130M	107M
Selling and Marketing Expenses	100M	97.3M	114M	130M	107M
General and Administrative Expenses	804M	922M	1B	1.04B	1.11B
Net Rental Expense, Total	32.5M	50M	52.4M	42.2M	56M
Stock-Based Comp., COGS (Total)	275M	285M	266M	247M	217M
Total Stock-Based Compensation	275M	285M	266M	247M	217M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.52B	1.76B	2.07B	2.65B	3.38B
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	1.52B	1.76B	2.07B	2.65B	3.38B
Accounts Receivable, Total	1.06B	749M	808M	877M	931M
Other Receivables	11.9M	71.2M	81M	52.4M	50.2M
Total Receivables	1.07B	820M	889M	930M	981M
Total Current Assets	2.59B	2.58B	2.96B	3.58B	4.36B
Gross Property Plant And Equipment	2.39B	2.6B	2.72B	3.07B	3.38B
Accumulated Depreciation	-1.46B	-1.57B	-1.68B	-1.86B	-2.15B
Net Property Plant And Equipment	937M	1.04B	1.05B	1.2B	1.23B
Long-term Investments	4.94B	4.14B	4.51B	5.04B	5.28B
Goodwill	2.69B	2.64B	2.64B	2.64B	2.64B
Other Intangibles, Total	913M	630M	507M	368M	274M
Deferred Tax Assets Long-Term	-	216M	194M	278M	188M
Other Long-Term Assets, Total	433M	401M	418M	355M	373M
Total Assets	12.51B	11.64B	12.28B	13.47B	14.34B
Liabilities
Accounts Payable, Total	318M	298M	315M	292M	324M
Accrued Expenses, Total	1.14B	989M	1.14B	220M	236M
Short-term Borrowings	75.9M	71.3M	72.3M	59.1M	21.8M
Current Portion of Leases	41.7M	40.8M	57.5M	31.9M	56M
Current Income Taxes Payable	77.9M	46M	66.2M	87.1M	54.9M
Other Current Liabilities	-	5.5M	5.4M	2.3M	6.9M
Total Current Liabilities	1.65B	1.45B	1.65B	692M	699M
Long-Term Debt	37.6M	31.7M	17.1M	-	-
Long-Term Leases	208M	289M	251M	247M	391M
Other Non Current Liabilities	358M	185M	67.6M	1.08B	1.2B
Total Liabilities	2.26B	1.96B	1.99B	2.02B	2.29B
Common Stock, Total	45.8M	44.9M	44.8M	44.6M	43.8M
Additional Paid In Capital	920M	438M	432M	312M	-
Retained Earnings	8.08B	8.41B	9.08B	10.04B	10.87B
Comprehensive Income and Other	-26.5M	-53M	-47.5M	-51.7M	-50.5M
Total Common Equity	9.02B	8.84B	9.51B	10.35B	10.86B
Minority Interest	1.23B	847M	786M	1.1B	1.19B
Total Equity	10.25B	9.69B	10.29B	11.45B	12.05B
Total Liabilities And Equity	12.51B	11.64B	12.28B	13.47B	14.34B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	228M	224M	224M	223M	218M
ECS Total Common Shares Outstanding	229M	224M	224M	223M	219M
Book Value / Share	39.37	39.41	42.45	46.4	49.69
Tangible Book Value	5.42B	5.57B	6.36B	7.33B	7.94B
Tangible Book Value Per Share	23.63	24.82	28.38	32.9	36.34
Total Debt	363M	433M	398M	338M	469M
Net Debt	-1.16B	-1.32B	-1.67B	-2.31B	-2.91B
Debt Equivalent Oper. Leases	260M	400M	419M	338M	448M
Minority Interest, Total (Incl. Fin. Div)	1.23B	847M	786M	1.1B	1.19B
Equity Method Investments, Total	1.07B	1.13B	1.06B	1.31B	1.07B
Account Code - Inventory Valuation	3	3	3	3	3
Land - (BS)	25.7M	25.7M	25.7M	25.7M	22.5M
Buildings, Total	472M	489M	491M	493M	466M
Machinery, Total	1.5B	1.57B	1.71B	1.91B	2.1B
Full Time Employees	7.53K	7.87K	7.91K	8.16K	7.77K

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	3.08B	1.56B	1.79B	2.1B	2.09B
Depreciation & Amortization - CF	205M	226M	255M	254M	278M
Amortization of Goodwill and Intangible Assets - (CF)	-	245M	227M	219M	196M
Depreciation & Amortization, Total	205M	471M	482M	473M	475M
(Gain) Loss on Sale of Investments - (CF)	-122M	211M	-461M	-340M	-452M
Asset Writedown & Restructuring Costs	-	175M	-	31.1M	131M
Stock-Based Compensation (CF)	275M	285M	266M	247M	217M
Other Operating Activities, Total	-70.1M	-288M	20.7M	-70.9M	129M
Change in Trading Asset Securities	14.9M	87.9M	-1.07B	-760M	-1B
Change In Accounts Receivable	-	-	-	-	-
Change In Accounts Payable	-	-	-	-	-
Change in Other Net Operating Assets	67.4M	-140M	194M	5.5M	170M
Cash from Operations	3.45B	2.36B	1.22B	1.69B	1.75B
Capital Expenditure	-239M	-238M	-308M	-423M	-274M
Cash Acquisitions	-2.47B	-	-	-	-
Divestitures	-	-8.7M	-56.8M	-15.8M	-63.1M
Investment in Marketable and Equity Securities, Total	1.58B	208M	531M	433M	656M
Other Investing Activities, Total	30.9M	-3.7M	-38.4M	-172M	-88.6M
Cash from Investing	-1.1B	-41.5M	128M	-178M	230M
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-1.14B	-850M	-254M	-337M	-621M
Common Dividends Paid	-1B	-1.11B	-1.12B	-1.14B	-1.14B
Common & Preferred Stock Dividends Paid	-1B	-1.11B	-1.12B	-1.14B	-1.14B
Special Dividend Paid	-700M	-	-	-	-
Other Financing Activities, Total	-148M	-120M	298M	536M	486M
Cash from Financing	-2.99B	-2.08B	-1.08B	-937M	-1.28B
Foreign Exchange Rate Adjustments	2.6M	9.5M	400K	-2.4M	-1.9M
Net Change in Cash	-632M	250M	269M	569M	704M
Supplemental Items
Cash Income Tax Paid (Refund)	949M	794M	632M	723M	595M
Levered Free Cash Flow	2.75B	1.96B	1.74B	1.69B	1.87B
Unlevered Free Cash Flow	2.75B	1.96B	1.74B	1.69B	1.87B
Change In Net Working Capital	-174M	-54.4M	-114M	80.1M	31.4M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	20.19	11.46	9.95	11.41	10.65
Return on Total Capital	23.34	13.34	11.44	13.07	12.18
Return On Equity %	31.74	14.54	18.38	19.65	18.79
Return on Common Equity	35.89	17.04	19.02	20.6	19.21
Margin Analysis
Gross Profit Margin %	60.98	54.96	49.63	51.94	51.27
SG&A Margin	12.21	16.48	18.08	17.02	17.4
EBITDA Margin %	51.44	41.37	36.92	39.81	38.88
EBITA Margin %	48.77	37.89	32.98	36.23	35.08
EBIT Margin %	48.77	34.11	29.47	33.14	32.39
Income From Continuing Operations Margin %	40.39	22.34	28.41	30.11	30.19
Net Income Margin %	40.18	24.01	27.69	29.61	28.53
Net Avail. For Common Margin %	39.14	23.45	27	28.82	27.84
Normalized Net Income Margin	32.6	22.82	22.57	24.5	24.46
Levered Free Cash Flow Margin	35.89	30.15	26.99	23.77	25.52
Unlevered Free Cash Flow Margin	35.89	30.15	26.99	23.77	25.52
Asset Turnover
Asset Turnover	0.66	0.54	0.54	0.55	0.53
Fixed Assets Turnover	8.77	6.58	6.2	6.3	6.02
Receivables Turnover (Average Receivables)	7.99	7.18	8.3	8.42	8.09
Short Term Liquidity
Current Ratio	1.57	1.77	1.79	5.17	6.23
Quick Ratio	1.57	1.77	1.79	5.17	6.23
Operating Cash Flow to Current Liabilities	2.09	1.63	0.74	2.43	2.51
Days Sales Outstanding (Average Receivables)	45.71	50.83	43.97	43.48	45.12
Average Days Payable Outstanding	30.65	38.45	34.68	32.86	31.66
Long Term Solvency
Total Debt/Equity	3.54	4.47	3.87	2.95	3.89
Total Debt / Total Capital	3.42	4.27	3.72	2.87	3.75
LT Debt/Equity	2.39	3.31	2.61	2.16	3.25
Long-Term Debt / Total Capital	2.31	3.17	2.51	2.09	3.12
Total Liabilities / Total Assets	18.03	16.8	16.19	15.01	15.96
Total Debt / EBITDA	0.09	0.16	0.16	0.12	0.16
Net Debt / EBITDA	-0.29	-0.48	-0.68	-0.81	-1
Total Debt / (EBITDA - Capex)	0.1	0.17	0.19	0.14	0.18
Net Debt / (EBITDA - Capex)	-0.31	-0.53	-0.78	-0.95	-1.11
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	23.61	-15.43	-0.43	9.8	3.12
Gross Profit, 1 Yr. Growth %	30.32	-23.78	-10.09	14.91	1.8
EBITDA, 1 Yr. Growth %	34.46	-31.99	-11.13	19.43	0.72
EBITA, 1 Yr. Growth %	36.28	-34.3	-13.33	21.81	-0.16
EBIT, 1 Yr. Growth %	36.28	-40.85	-13.99	24.85	0.78
Earnings From Cont. Operations, 1 Yr. Growth %	22.8	-53.22	26.63	16.35	3.39
Net Income, 1 Yr. Growth %	29.93	-49.47	14.81	17.41	-0.62
Normalized Net Income, 1 Yr. Growth %	33.33	-40.79	-1.55	20.26	2.95
Diluted EPS Before Extra, 1 Yr. Growth %	31.46	-48.93	15.82	17.91	0.98
Accounts Receivable, 1 Yr. Growth %	22.62	-29.25	7.91	8.6	6.13
Net Property, Plant and Equip., 1 Yr. Growth %	15.3	10.42	1.22	14.9	2.03
Total Assets, 1 Yr. Growth %	17.36	-6.92	5.46	9.72	6.46
Tangible Book Value, 1 Yr. Growth %	-23.08	2.78	14.16	15.41	8.3
Common Equity, 1 Yr. Growth %	17.07	-2.03	7.53	8.84	4.98
Cash From Operations, 1 Yr. Growth %	79.89	-31.65	-48.33	38.27	4.02
Capital Expenditures, 1 Yr. Growth %	11.42	-0.63	29.59	37.51	-35.24
Levered Free Cash Flow, 1 Yr. Growth %	38.75	-28.95	-10.88	98.67	10.72
Unlevered Free Cash Flow, 1 Yr. Growth %	38.75	-28.95	-10.88	98.67	10.72
Dividend Per Share, 1 Yr. Growth %	20	11.11	1.67	1.64	2.42
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	16.86	2.24	-8.23	4.56	6.41
Gross Profit, 2 Yr. CAGR %	20.3	-0.34	-17.22	1.64	8.15
EBITDA, 2 Yr. CAGR %	23.74	-4.37	-22.26	-0.62	9.2
EBITA, 2 Yr. CAGR %	25.2	-5.38	-24.54	-1.21	9.74
EBIT, 2 Yr. CAGR %	25.2	-10.22	-28.67	-0.79	11.56
Earnings From Cont. Operations, 2 Yr. CAGR %	17.38	-24.21	-23.03	21.38	9.68
Net Income, 2 Yr. CAGR %	20.27	-18.97	-23.83	16.1	8.02
Normalized Net Income, 2 Yr. CAGR %	20.87	-11.15	-23.65	4.53	10.77
Diluted EPS Before Extra, 2 Yr. CAGR %	22.8	-18.06	-23.09	16.86	9.12
Accounts Receivable, 2 Yr. CAGR %	27.93	-6.86	-12.63	8.25	7.36
Net Property, Plant and Equip., 2 Yr. CAGR %	9.26	12.84	5.72	7.84	8.27
Total Assets, 2 Yr. CAGR %	15.79	4.52	-0.92	7.57	8.07
Tangible Book Value, 2 Yr. CAGR %	-8.27	-11.08	8.32	14.78	11.8
Common Equity, 2 Yr. CAGR %	12.71	7.1	2.64	8.18	6.89
Cash From Operations, 2 Yr. CAGR %	50.57	10.89	-40.57	-15.48	19.93
Capital Expenditures, 2 Yr. CAGR %	8.1	5.22	13.48	33.49	-5.63
Levered Free Cash Flow, 2 Yr. CAGR %	26.76	-0.71	-20.42	-9.65	47.19
Unlevered Free Cash Flow, 2 Yr. CAGR %	26.76	-0.71	-20.42	-9.65	47.19
Dividend Per Share, 2 Yr. CAGR %	19.21	15.47	6.28	1.65	2.03
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	12.61	4.92	1.34	-2.58	4.08
Gross Profit, 3 Yr. CAGR %	14.39	3.32	-3.7	-7.66	1.69
EBITDA, 3 Yr. CAGR %	16.35	1.36	-6.68	-10.56	-0.17
EBITA, 3 Yr. CAGR %	16.84	0.99	-8.11	-11.77	-0.86
EBIT, 3 Yr. CAGR %	16.84	-2.49	-11.49	-14.35	-0.27
Earnings From Cont. Operations, 3 Yr. CAGR %	20.55	-13.62	-10.06	-11.66	15.06
Net Income, 3 Yr. CAGR %	18.83	-9.92	-8.99	-12.01	10.24
Normalized Net Income, 3 Yr. CAGR %	15.87	-4.72	-8.06	-11.43	4
Diluted EPS Before Extra, 3 Yr. CAGR %	21.75	-8.34	-8.04	-11.32	11.31
Accounts Receivable, 3 Yr. CAGR %	24.41	5.01	-2.18	-6.06	7.54
Net Property, Plant and Equip., 3 Yr. CAGR %	12.33	9.65	8.82	8.7	5.87
Total Assets, 3 Yr. CAGR %	17.61	7.66	4.83	2.5	7.2
Tangible Book Value, 3 Yr. CAGR %	-0.26	-4.72	-3.36	10.64	12.58
Common Equity, 3 Yr. CAGR %	13.79	7.57	7.24	4.67	7.1
Cash From Operations, 3 Yr. CAGR %	28.68	15.72	-14.03	-21.25	-9.42
Capital Expenditures, 3 Yr. CAGR %	12.37	5.11	12.79	20.98	4.89
Levered Free Cash Flow, 3 Yr. CAGR %	14.9	4.51	-4.22	-15.08	-3.31
Unlevered Free Cash Flow, 3 Yr. CAGR %	14.9	4.51	-4.22	-15.08	-3.31
Dividend Per Share, 3 Yr. CAGR %	15.55	16.45	10.67	4.71	1.91
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	12.36	5.97	3.76	4.78	3.34
Gross Profit, 5 Yr. CAGR %	14.12	5.1	0.51	2.65	0.88
EBITDA, 5 Yr. CAGR %	15.35	4.04	-0.98	1.84	-0.63
EBITA, 5 Yr. CAGR %	15.77	3.61	-1.91	1.49	-1.35
EBIT, 5 Yr. CAGR %	15.77	1.46	-4.09	-0.3	-2.9
Earnings From Cont. Operations, 5 Yr. CAGR %	19.83	-1.72	0.75	-1.03	-2.63
Net Income, 5 Yr. CAGR %	20.47	0.79	-0.54	-0.29	-2.53
Normalized Net Income, 5 Yr. CAGR %	15.29	0.41	-1.94	0.3	-0.94
Diluted EPS Before Extra, 5 Yr. CAGR %	22.53	2.33	1.31	1.01	-1.53
Accounts Receivable, 5 Yr. CAGR %	18.39	5.78	8.01	6.29	1.53
Net Property, Plant and Equip., 5 Yr. CAGR %	8.79	9.68	9.64	8.92	8.6
Total Assets, 5 Yr. CAGR %	14.98	9.09	9.81	7.62	6.12
Tangible Book Value, 5 Yr. CAGR %	4.52	1.53	3.09	2.65	2.44
Common Equity, 5 Yr. CAGR %	12.49	8.7	9.19	7.81	7.1
Cash From Operations, 5 Yr. CAGR %	82.5	59.37	-5.53	2.05	-1.79
Capital Expenditures, 5 Yr. CAGR %	10.02	5.01	12.81	15.66	5.02
Levered Free Cash Flow, 5 Yr. CAGR %	14.89	6.18	-0.8	-0.32	-1.21
Unlevered Free Cash Flow, 5 Yr. CAGR %	14.89	6.18	-0.8	-0.32	-1.21
Dividend Per Share, 5 Yr. CAGR %	14.87	16.05	11.75	10.29	7.13